Eli Lilly's Breakthrough Weight-Loss Pill Soars Shares by 13% in Premarket Trading
Eli Lilly and Co. shares surged 13% after announcing positive phase 3 results for orforglipron, a groundbreaking weight-loss and diabetes pill. The drug, the first of its kind to c...